Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial.
Oppelt P, Ley J, Daly M, Rich J, Paniello R, Jackson RS, Pipkorn P, Liu J, Gay H, Palka K, Neupane P, Powell S, Spanos WC, Gitau M, Zevallos J, Thorstad W, Adkins D. Oppelt P, et al. Among authors: gitau m. Med Oncol. 2021 Mar 8;38(4):35. doi: 10.1007/s12032-021-01479-w. Med Oncol. 2021. PMID: 33683482 Clinical Trial.
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study.
Powell SF, Gold KA, Gitau MM, Sumey CJ, Lohr MM, McGraw SC, Nowak RK, Jensen AW, Blanchard MJ, Fischer CD, Bykowski J, Ellison CA, Black LJ, Thompson PA, Callejas-Valera JL, Lee JH, Cohen EEW, Spanos WC. Powell SF, et al. Among authors: gitau mm. J Clin Oncol. 2020 Jul 20;38(21):2427-2437. doi: 10.1200/JCO.19.03156. Epub 2020 Jun 1. J Clin Oncol. 2020. PMID: 32479189 Free PMC article. Clinical Trial.
Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial.
Adkins D, Ley J, Atiq O, Powell S, Spanos WC, Gitau M, Rigden C, Palka K, Liu J, Oppelt P. Adkins D, et al. Among authors: gitau m. Oral Oncol. 2021 Apr;115:105173. doi: 10.1016/j.oraloncology.2020.105173. Epub 2021 Feb 3. Oral Oncol. 2021. PMID: 33548860 Free PMC article. Clinical Trial.
Implementation of a standardized approach to borderline resectable pancreatic cancer in a multisite community oncology program.
Bleeker JS, Sumey CJ, Powell SF, Steen PD, Keppen MD, Lohr M, Thambi-Pillai T, Kurniali P, Mazurczak M, Gitau MM, Blanchard MJ, Nowak RK, McGraw S, Sticca R, Tuvin D, Timmerman G. Bleeker JS, et al. Among authors: gitau mm. Surg Open Sci. 2020 Jul 29;2(4):25-31. doi: 10.1016/j.sopen.2020.07.003. eCollection 2020 Oct. Surg Open Sci. 2020. PMID: 32954245 Free PMC article.
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study.
Powell SF, Dib EG, Bleeker JS, Keppen MD, Mazurczak M, Hack KM, Gitau MM, Steen PD, Terstriep SA, Reynolds J, Landsverk ML, Chan CH, Nelson ME, Thompson PA, Ellison C, Black LJ, Ford JM, Chung JH, Anhorn R, Gaba AG. Powell SF, et al. Among authors: gitau mm. JCO Precis Oncol. 2018 Nov;2:1-12. doi: 10.1200/PO.17.00220. JCO Precis Oncol. 2018. PMID: 35135120
45 results